Patent · US Active

Non-cross-reactive anti IgG antibodies

US9957331B2 · kind B2 · utility

0Cited by

4References

12Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Ulrich Essig · Wissen, DE
Stefan Klostermann · Schwanau, DE
Frank Kowalewsky · Munich, DE
Kay-Gunnar Stubenrauch · Frauenfeld, CH
Rudolf Vogel · Salzgitter, DE
Uwe Wessels · Penzberg, DE

Key dates

Filing date	Oct 18, 2010
Grant date	May 1, 2018
Priority date	—
Expiry date	Jul 21, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/6854
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Herein are reported the cell lines DSM ACC3006, DSM ACC3007, and DSM ACC3008, as well as the antibodies obtained from the cell lines and the use of an antibody obtained from the cell lines in an immunoassay. Also are reported antibodies binding to human or chimpanzee IgG and not binding to canine and marmoset IgG and antibodies specifically binding to an IgG 1 that comprises a kappa light chain constant domain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.